Sernova Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
167.97 M |
Public Float |
- |
Sernova Corp. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.02 |
Market Cap |
CAD37.97 M |
Shares Outstanding |
172.24 M |
Public Float |
165.73 M |
Address |
700 Collip Circle London Ontario N6G 4X8 Canada |
Employees | - |
Website | http://www.sernova.com |
Updated | 07/08/2019 |
Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. It also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. |